期刊文献+

HPV感染与宫颈癌的研究进展 被引量:3

Research on the Human Papillomavirus Infection and Cervical Cancer
下载PDF
导出
摘要 宫颈癌是全球女性恶性肿瘤的常见疾病,是危害广大妇女健康的主要肿瘤之一。高危型人乳头瘤病毒(HPV)感染是宫颈癌的发病因子,从HPV(human papilloma virus)感染发展为宫颈癌的时间大约为15年左右。本文从HPV的致癌机制、HPV各基因型与肿瘤的相关性、HPV基因分型检测以及HPV的筛查指南等多角度来进行阐述。希望通过此文章可以提高我国民众对HPV的认知程度并更好地预防宫颈癌,远离HPV感染。 Cervical cancer is one of the most common malignant tumors among women.High-risk human papillomavirus(HPV) infection are risk factors for cervical cancer.The development of cervical cancer from HPV infection is about 15 years.In this paper,we described the carcinogenic mechanism of HPV,the correlation between different HPV genotypes and carcinogenesis,how to perform a genotyping assay and HPV screening Guidelines,in order to improve awareness of HPV and promote cervical cancer prevention.
作者 苏雅 刘云春
出处 《生命科学仪器》 2015年第3期12-15,共4页 Life Science Instruments
基金 云南省大理地区女性高危HPV亚型检测系统的建立 国家自然科学基金项目(81260267)
关键词 人乳头瘤病毒 感染 宫颈癌:筛查指南 HPV(human papillomavirus) Infection Cervical cancer Screening Guidelines
  • 相关文献

参考文献25

  • 1Parkin D M, Bray F, Ferlay J, et al Estimating the world cancerburden: Globocan 2000. Int J Cancer, 2001,94(2): 153 -156.
  • 2Parkin D M. The global health burden of infection-associatedcancers in the year 2002. 2006, 118 (12): 3030-3044.
  • 3Ferlay J, Shin H,Bray F, et al GLOBOCAN 2008: cancer incidenceand mortality worldwide: Lyon, France: International Agency forResearch on Cancer, 2008.
  • 4魏金霞,闵丽,陈晓英,梁秋萍.1478例妇女宫颈癌筛查结果[J].江苏卫生保健(学术版),2011,13(4):40-41. 被引量:5
  • 5Clavel C,Masure M,Bory J P, et al. Human papillomavirustesting in primary screening for the detection of high-risk lesions: astudy of 7932 woman. Br J Cancer, 2001, 89: 1616-1623.
  • 6徐伟莉.病理学检查在宫颈上皮内瘤变诊断中的应用体会[J].中国实用医药,2010,5(23):106-108. 被引量:6
  • 7车雅敏,王家璧.HPV在宫颈癌发病中的作用机制研究[J].国外医学(肿瘤学分册),2004,31(4):306-309. 被引量:33
  • 8Herrero R, Castellsague X,Pawlita M, et al. Human papillomavirusand oral cancer: the International Agency for research on CancerMulticenter Study. J Natl Cancer Inst, 2003, 95: 1772 -1783.
  • 9Nichols A C, Dhaliwal SS, Palma D A,et al. Does HPV type affectoutcome in oropharyngeal cancer. J Otolaryngol Head NeckSurg,2013,42(1) :9.
  • 10Bosch F X,Manos M M, Munoz N, et al. Prevalence of humanpapillomavirus in cervical cancer: a worldwide perspective. J NatlCancer Inst,1995, 87: 796-802.

二级参考文献44

  • 1程淑霞,赵先兰.宫颈癌及癌前病变中p16^(INK4A)与HPV的关系[J].国外医学(妇产科学分册),2006,33(5):317-320. 被引量:8
  • 2曾泽毅.中华妇产科学[M].2版.北京:人民卫生出版社,2004,11:461.
  • 3Bonfiglio TA.Gynecologic cytopathology.Historicalperspective,current status,and future outlook.Pathol Case Rev,2005,10(3):98-105.
  • 4World Health Organization (WHO) Initiative for Vaccine Research. Human Papilloma Infection and Cervical Cancer[S].Geneva, Switzerland:WHO.2008.
  • 5zur Hausen H.Papillomaviruses and cancer:from basic studies to clinical applieation[J]. Nat Rev Cancer,2002,2(5):342-350.
  • 6Winer RL, Lee SK, Hughes JP, et al. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students[J].Am J Epidemiol, 2003,157(3):218- 226.
  • 7Sellors JW, Karwalajtys TL, Kaczorowski J, et al. Incidence, clearance and predictors of human papillomavirus infection in women[J].CMAJ,2003,168(4):421-425.
  • 8Castellsagué X, Muoz N. Chapter 3: Cofactors in human papillomavirus carcinogenesis— role of parity, oral contraceptives and tobacco smoking[J].J Natl Cancer Inst Monogr,2003, (31):20-28.
  • 9Muoz N, Bosch FX, de Sanjosé S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer[J].N Engl J Med, 2003,348(6):518-527.
  • 10Office for National Statistics. Cancer statistics 2004: registrations seriesMB1No 35 [M].London: Office for National Statistics,2008:34-39.

共引文献44

同被引文献35

  • 1Zur Hausen H. Condynomata acuminate and human genital cancer [J]. Cancer Res, 1976, 36(2) : 794.
  • 2Pirog EC, Lloveras B, Molijin A, et al. HPV prevalence and geno- types in different histologieal subtypes of cervical adenocarcinoa, a worldwide analysis of 760 cases[J]. Mod Pathol, 2014, 27(12) : 1559 - 1567.
  • 3Forman D, de Martel C, Lacey C J, et al. Global burden of human papillomavirus and related diseases[ J]. Vaccine, 2012, 30(Suppl 5) : F12 - F23.
  • 4Marra F, Cloutier K, Oteng B, et al. Effictiveness and cost effec- tiveness of human pappillomavirus vaccine[ J J. Pharacoeconomics, 2009, 27(2) : 127 -147.
  • 5Slama J, Drazdakova M, Dunder P, et al. High - risk human pap- illomavirus DNA in the primary tumor, sentine, and nonsentinel pelvic lymph nodes in patients with early -stage cervical cancer:a correlation with histopathalogy[ J]. Int J Gyneco Cancer, 2009, 19 (4) : 703 - 707.
  • 6Karwa/ajtys T, Howard M, Sellors JW, et al. Vagina/self sampling versus physician cervical sampling fou HPV among younger and ol- der women[J]. Sex Transm Infect, 2006, 82(4): 227-339.
  • 7李霓,代敏.中国妇女人乳头状瘤病毒感染的多中心横断面研究[J].中华疾病控制杂志,2008,12(5):411-415. 被引量:97
  • 8李军霞,卢静.妊娠期高血压疾病病因研究进展[J].河北医药,2010,32(9):1142-1144. 被引量:36
  • 9韩历丽,齐庆青,王朝,张月,董翠英,王连英.北京市两癌筛查主要问题与经验探讨[J].实用预防医学,2011,18(3):566-568. 被引量:40
  • 10陈洁清,张映辉.宫颈癌筛查三阶梯技术临床应用探讨[J].国际生殖健康/计划生育杂志,2012,31(4):273-275. 被引量:8

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部